M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way

BACKGROUND: The small tyrosine kinase inhibitors (TKIs) subversively altered the lung cancer treatments, but patients will inevitably face the therapy resistance and disease recurrence. We aim to explore the potential roles of non-coding RNAs in sensitizing the TKIs effects. Methods: Multiple cellul...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Peng, Zi-Yang, Gao, Shan, Wang, Qing-Shi, Wang, Rui, Li, Xiang, Xiao, Guo-Dong, Zhang, Jing, Ren, Hong, Tang, Shou-Ching, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520306/
https://www.ncbi.nlm.nih.gov/pubmed/34656164
http://dx.doi.org/10.1186/s13046-021-02137-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520306/
https://www.ncbi.nlm.nih.gov/pubmed/34656164
http://dx.doi.org/10.1186/s13046-021-02137-9

Ejemplares similares